The Global ATMP Quality Leader provides administrative and technical leadership for cell and gene therapy (CGT) quality across Lilly. The role establishes and executes quality strategy for AAV gene therapy, cell therapy, and LNP-based platforms from clinical development through commercialization. It oversees quality assurance and quality control for Product Research and Development, the LP2 Lebanon facility, external collaboration partners and contract manufacturers, and acquired company quality organizations, ensuring compliance with Lilly Global Quality Standards, current Good Manufacturing Practices, and applicable regulatory requirements. The leader builds and scales a streamlined ATMP quality organization with modality expertise, providing quality-system, regulatory-submission, and inspection support for clinical and commercial supply. The position collaborates across Quality, PR&D, LRM, Manufacturing, TS/MS, Device Development, Regulatory, and external partners. The organization is intended to scale as the portfolio and modalities evolve. The role has final quality decision rights for CGT matters, including quality sign-off on regulatory submissions, approval of quality strategy and systems, and qualification or disqualification decisions involving CDMOs, suppliers, and external partners. It leads quality governance, supports regulatory communications and inspections, develops the organization and its people, oversees strategic and budget planning, and advances quality through technology, data governance, and continuous improvement. The position is based in Indianapolis, with periodic presence at the Lebanon, Indiana LP2 facility and travel to acquired company sites as needed. Travel is approximately 15–20%.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive